{"nctId":"NCT02354352","briefTitle":"Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy","startDateStruct":{"date":"2015-03-20","type":"ACTUAL"},"conditions":["Duchenne Muscular Dystrophy"],"count":52,"armGroups":[{"label":"Eplerenone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Eplerenone"]},{"label":"Spironolactone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Spironolactone"]}],"interventions":[{"name":"Eplerenone","otherNames":["Inspra"]},{"name":"Spironolactone","otherNames":["Aldactone"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Boys age ≥7 years with DMD confirmed clinically and by mutation analysis able to undergo cardiac magnetic resonance (CMR) without sedation\n* LV EF ≥45% (+/-5%) by clinically-acquired echocardiography, nuclear scan or cardiac MRI done within 2 weeks of enrollment\n\nExclusion Criteria:\n\n* Non-MR compatible implants\n* Severe claustrophobia\n* Gadolinium contrast allergy\n* Kidney disease\n* Prior use of or allergy to aldosterone antagonist\n* Use of other investigational therapy.","healthyVolunteers":false,"sex":"MALE","minimumAge":"7 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Left Ventricular Strain","description":"a sensitive measure of heart muscle function","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":null},{"groupId":"OG001","value":"0.4","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":26},"commonTop":["Nausea","Rash","Gynecomastia","Nephrolithiasis"]}}}